Table 1 Patient characteristics

From: Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer

 

S-1 alone

S-1 plus CPT-11

No. of patients

27

26

Age (years)

  

 Median

58

61

 Range

29–78

34–80

Gender

  

 Male/female

20/7

19/7

PS

  

 0/1/2

19/5/3

20/5/1

Histology

  

 Intestinal/diffuse

10/17

11/15

Metastasis

  

 Synchronous/metachronous

10/17

12/14

Adjuvant chemotherapy

  

 Yes/no

14/13

12/14

Metastatic site

  

 Liver

8

8

 Lymph node

15

17

 Lung

5

3

 Others

5

8

Second-line chemotherapy

  

 Taxanes

5

10

 Cisplatin+CPT-11

2

0

 CPT-11

3

0

Back to article page